Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Goserelin on the Protection of Ovarian Reserve During (Neo)Adjuvant Chemotherapy for Young Breast Cancer Patients: A Prospective Cohort Trial

NCT02430103 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT02430103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02430103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Goserelin on the Protection of Ovarian Reserve During (Neo)Adjuvant Chemotherapy for Young Breast Cancer Patients: A Prospective Cohort Trial
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
December 25, 2015
Completion date
December 31, 2024
Enrollment
349 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer